Clinical Trial Update: Post-CA Neuroprotection With Magnesium [Phase 1]

View source ↗

Summary

Phase 1 trial studying magnesium sulfate for neuroprotection after cardiac arrest with return of spontaneous circulation; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: NYU Langone Health | Conditions: Cardiac Arrest, Return of Spontaneous Circulation | Phase 1 | Status: RECRUITING